Retension Pharmaceuticals, Inc. (RTSN)

Retension Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Retension Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-11.94	-6.3	-1.91
Share-Based Compensation	-	0.25	0.14
Other Operating Activities	0.05	-1.72	0.01
Operating Cash Flow	-11.89	-7.78	-1.76
Operating Cash Flow Growth	-	-	-

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	18.5	3.61
Financing Cash Flow	7.12	18.5	3.61

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	-4.77	10.72	1.86

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-11.89	-7.78	-1.76
Free Cash Flow Growth	-	-	-